X0306 4 2021-04-27 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001856380 Treace John T. C/O TREACE MEDICAL CONCEPTS, INC. 203 FORT WADE RD., SUITE 150 PONTE VEDRA FL 32081 1 1 1 0 Chief Executive Officer Common Stock 2021-04-27 4 C 0 299510 A 11171385 D Common Stock 2021-04-27 4 S 0 5253805 17.00 D 5917580 D Common Stock 1605000 I By Wife Common Stock 1471250 I By Wife as co-trustee of the JTT Irrevocable Trust dated September 30, 2020 Common Stock 1839063 I As Trustee of the Tracy W. Treace Irrevocable Trust dated September 25, 2020 Series A Preferred Stock 2021-04-27 4 J 0 6932 0.00 A Common Stock 6932 299510 D Series A Preferred Stock 2021-04-27 4 C 0 299510 0.00 D Common Stock 299510 0 D Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters. The Reporting Person disclaims beneficial ownership of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee. The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend. /s/ Jaime A. Frias as Attorney-in-fact for John T. Treace 2021-04-29